这是一篇来自已证抗体库的有关人类 eNOS的综述,是根据104篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合eNOS 抗体。
eNOS 同义词: ECNOS; eNOS; nitric oxide synthase, endothelial; EC-NOS; NOS type III; NOSIII; cNOS; constitutive NOS; endothelial NOS; nitric oxide synthase 3 (endothelial cell); nitric oxide synthase 3 transcript variant eNOS-delta20; nitric oxide synthase 3 transcript variant eNOS-delta20-21; nitric oxide synthase 3 transcript variant eNOS-delta21

艾博抗(上海)贸易有限公司
小鼠 单克隆(M221)
  • 免疫印迹; 人类; 1:4000; 图 7b
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在人类样品上浓度为1:4000 (图 7b). Sci Rep (2016) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 人类; 1:1000; 图 7
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 7). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠; 1:100; 图 3
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, 5589)被用于被用于免疫组化-石蜡切片在大鼠样品上浓度为1:100 (图 3). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 狗; 1:500; 图 s1a
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫印迹在狗样品上浓度为1:500 (图 s1a). J Am Heart Assoc (2016) ncbi
兔 多克隆
  • 免疫组化; 猪; 图 9
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫组化在猪样品上 (图 9). J Am Heart Assoc (2016) ncbi
兔 多克隆
  • 免疫组化; 猪
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫组化在猪样品上. Regen Med (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 6a
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫印迹在大鼠样品上浓度为1:1000 (图 6a). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:100
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫细胞化学在人类样品上浓度为1:100. Stem Cells (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab15280)被用于被用于免疫组化-石蜡切片在小鼠样品上. J Am Heart Assoc (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫印迹在小鼠样品上. J Physiol (2013) ncbi
赛默飞世尔
兔 多克隆
  • 免疫印迹; 小鼠; 1:400; 图 s3a
赛默飞世尔 eNOS抗体(Invitrogen, PA3-031A)被用于被用于免疫印迹在小鼠样品上浓度为1:400 (图 s3a). Nitric Oxide (2018) ncbi
小鼠 单克隆(6H2)
  • 免疫细胞化学; 人类; 图 5h
赛默飞世尔 eNOS抗体(Pierce, MA5-15559)被用于被用于免疫细胞化学在人类样品上 (图 5h). Acta Histochem (2017) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠; 图 3
赛默飞世尔 eNOS抗体(Invitrogen, RB-9279-P)被用于被用于免疫组化-石蜡切片在大鼠样品上 (图 3). Exp Eye Res (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 大鼠; 1:250; 图 2
赛默飞世尔 eNOS抗体(Pierce, PA3-031A)被用于被用于免疫组化-石蜡切片在大鼠样品上浓度为1:250 (图 2). Ren Fail (2016) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:250; 图 2
  • 免疫印迹; 大鼠; 1:1000; 图 3
赛默飞世尔 eNOS抗体(Pierce antibody product, PA3-031A)被用于被用于免疫组化在大鼠样品上浓度为1:250 (图 2) 和 被用于免疫印迹在大鼠样品上浓度为1:1000 (图 3). Syst Biol Reprod Med (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠
赛默飞世尔 eNOS抗体(Thermo Scientific, PA1-037)被用于被用于免疫组化-石蜡切片在小鼠样品上. J Biomech (2015) ncbi
兔 多克隆
  • 免疫印迹; green crab; 1:100
赛默飞世尔 eNOS抗体(Thermo, PA1-38835)被用于被用于免疫印迹在green crab样品上浓度为1:100. J Exp Biol (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:50
赛默飞世尔 eNOS抗体(Neomarker, RB-1711-P)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:50. Ann Vasc Surg (2014) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:100
赛默飞世尔 eNOS抗体(Neomarkers, RB-1711-P1)被用于被用于免疫组化在大鼠样品上浓度为1:100. Respir Res (2012) ncbi
圣克鲁斯生物技术
小鼠 单克隆(A-9)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 eNOS抗体(Santa Cruz Biotechnology, A-9)被用于被用于免疫印迹在人类样品上 (图 4). PLoS Genet (2016) ncbi
小鼠 单克隆(pT495.33)
  • 免疫印迹; 大鼠; 1:1000
圣克鲁斯生物技术 eNOS抗体(Santa Cruz, sc-136519)被用于被用于免疫印迹在大鼠样品上浓度为1:1000. Free Radic Biol Med (2014) ncbi
小鼠 单克隆(B-5)
  • 免疫印迹; 小鼠; 1:500
圣克鲁斯生物技术 eNOS抗体(Santa Cruz Biotechnology, sc-136977)被用于被用于免疫印迹在小鼠样品上浓度为1:500. Clin Exp Pharmacol Physiol (2014) ncbi
小鼠 单克隆(A-9)
  • 免疫印迹; 大鼠; 1:1000
圣克鲁斯生物技术 eNOS抗体(Santa Cruz Biotech, sc-376751)被用于被用于免疫印迹在大鼠样品上浓度为1:1000. PLoS ONE (2013) ncbi
GeneTex
兔 多克隆
  • 免疫印迹; 大鼠; 1:800; 图 4
GeneTex eNOS抗体(GeneTex Inc., GT50505)被用于被用于免疫印迹在大鼠样品上浓度为1:800 (图 4). Respiration (2016) ncbi
Biorbyt
兔 多克隆
  • 免疫印迹; 人类; 图 1c
Biorbyt eNOS抗体(Biorbyt, orb29800)被用于被用于免疫印迹在人类样品上 (图 1c). Cell Physiol Biochem (2018) ncbi
赛信通(上海)生物试剂有限公司
兔 多克隆
  • 免疫印迹; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在小鼠样品上 (图 2b). Cell (2018) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在小鼠样品上 (图 2b). Sci Transl Med (2017) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 人类; 图 9e
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样品上 (图 9e). J Clin Invest (2017) ncbi
小鼠 单克隆(6H2)
  • 免疫印迹; 人类; 图 9e
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 5880)被用于被用于免疫印迹在人类样品上 (图 9e). J Clin Invest (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上 (图 2a). Int J Radiat Biol (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上 (图 2a). Int J Radiat Biol (2017) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 人类; 图 5m, s4l
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样品上 (图 5m, s4l). Mol Cell (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 3b). FASEB J (2017) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 人类; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 3b). FASEB J (2017) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 7d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 7d). J Vasc Res (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 8I
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上 (图 8I). Autophagy (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 s7h
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上 (图 s7h). J Clin Invest (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 s7h
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上 (图 s7h). J Clin Invest (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上 (图 1b). J Clin Invest (2016) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9570S)被用于被用于免疫印迹在人类样品上 (图 5b). Physiol Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9571)被用于被用于免疫印迹在人类样品上 (图 5d). Am J Physiol Heart Circ Physiol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 3c
赛信通(上海)生物试剂有限公司 eNOS抗体(cell signalling, 9572)被用于被用于免疫印迹在人类样品上 (图 3c). J Cereb Blood Flow Metab (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 s6d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s6d). Nature (2016) ncbi
兔 单克隆(C9C3)
  • 免疫细胞化学; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9570)被用于被用于免疫细胞化学在小鼠样品上 (图 2b). Cell Res (2016) ncbi
兔 单克隆(49G3)
  • 免疫印迹; 人类; 图 s1
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Tech, 9586)被用于被用于免疫印迹在人类样品上 (图 s1). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9574)被用于被用于免疫印迹在人类样品上 (图 3d). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上 (图 3d). Sci Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9572)被用于被用于免疫印迹在小鼠样品上浓度为1:2000 (图 3). Oxid Med Cell Longev (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9571)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 3). Oxid Med Cell Longev (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9574)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 3). Oxid Med Cell Longev (2016) ncbi
兔 单克隆(C9C3)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图 3). J Clin Invest (2016) ncbi
兔 多克隆
  • 免疫印迹; 猪; 图 10
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9574)被用于被用于免疫印迹在猪样品上 (图 10). J Biol Chem (2016) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 猪; 图 10
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9570)被用于被用于免疫印迹在猪样品上 (图 10). J Biol Chem (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5b
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 6e
  • 免疫印迹; 小鼠; 1:1000; 图 6f
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 5b), 被用于免疫组化-冰冻切片在小鼠样品上浓度为1:100 (图 6e) 和 被用于免疫印迹在小鼠样品上浓度为1:1000 (图 6f). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 5
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9571)被用于被用于免疫印迹在小鼠样品上 (图 5). Biochim Biophys Acta (2016) ncbi
兔 单克隆(49G3)
  • 免疫印迹; 小鼠; 图 5
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9586)被用于被用于免疫印迹在小鼠样品上 (图 5). Biochim Biophys Acta (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signalling, 9571)被用于被用于免疫印迹在小鼠样品上浓度为1:2000 (图 3). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signalling, 9574)被用于被用于免疫印迹在小鼠样品上浓度为1:500 (图 3). Nat Commun (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 4b). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 6a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在小鼠样品上浓度为1:500 (图 6a). Free Radic Biol Med (2015) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样品上 (图 3a). J Biol Chem (2015) ncbi
兔 多克隆
  • 其他; 小鼠; 1:1000; 图 s1
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于其他在小鼠样品上浓度为1:1000 (图 s1). Front Microbiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在大鼠样品上浓度为1:500. Am J Physiol Heart Circ Physiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 6
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 6). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 6
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 6). PLoS ONE (2015) ncbi
兔 单克隆(49G3)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9586)被用于被用于免疫印迹在人类样品上 (图 5b). PLoS ONE (2015) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样品上 (图 5b). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 7b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9572)被用于被用于免疫印迹在小鼠样品上 (图 7b). Diabetes (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 7b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9571)被用于被用于免疫印迹在小鼠样品上 (图 7b). Diabetes (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 2
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signalling, 9572S)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 2). Am J Physiol Heart Circ Physiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图 5
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上浓度为1:500 (图 5). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:500; 图 5
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上浓度为1:500 (图 5). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上. J Diabetes (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上. J Diabetes (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 S2
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9572)被用于被用于免疫印迹在人类样品上 (图 S2). Oncotarget (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 eNOS抗体(Cst, 9571)被用于被用于免疫印迹在小鼠样品上. J Proteome Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 eNOS抗体(Cst, 9572)被用于被用于免疫印迹在小鼠样品上. J Proteome Res (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 9
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样品上 (图 9). Mol Cell Biol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 9
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样品上 (图 9). Mol Cell Biol (2015) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 小鼠; 1:1000; 图 s3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, C9C3)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s3). Nat Commun (2015) ncbi
兔 单克隆(49G3)
  • 其他; 人类; 1:100; 图 6
  • 免疫组化-石蜡切片; 人类; 1:100; 图 7c,8b
  • 其他; 小鼠; 1:100; 图 6
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 4a,4b,4c,4d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9586)被用于被用于其他在人类样品上浓度为1:100 (图 6), 被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图 7c,8b), 被用于其他在小鼠样品上浓度为1:100 (图 6) 和 被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图 4a,4b,4c,4d). Int J Mol Sci (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signalling, 9571)被用于被用于免疫印迹在小鼠样品上. Am J Physiol Heart Circ Physiol (2015) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9571)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 3). Am J Physiol Heart Circ Physiol (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在大鼠样品上浓度为1:1000. Vascul Pharmacol (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在大鼠样品上浓度为1:1000. Vascul Pharmacol (2014) ncbi
兔 多克隆
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在大鼠样品上. Toxicol Pathol (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 s6
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s6). Nat Commun (2014) ncbi
兔 单克隆(49G3)
  • 免疫印迹; 小鼠; 1:1000; 图 s6
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9586)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s6). Nat Commun (2014) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:25
  • 免疫印迹; 小鼠; 1:300
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571L)被用于被用于免疫组化-冰冻切片在小鼠样品上浓度为1:25 和 被用于免疫印迹在小鼠样品上浓度为1:300. J Sex Med (2014) ncbi
兔 单克隆(C9C3)
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在大鼠样品上浓度为1:1000. Diabetes Res Clin Pract (2013) ncbi
碧迪BD
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 图 2b
碧迪BD eNOS抗体(BD, 610296)被用于被用于免疫印迹在小鼠样品上 (图 2b). Sci Transl Med (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 图 1c
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在大鼠样品上 (图 1c). PLoS ONE (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500; 图 7e
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 7e). J Vasc Res (2017) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
碧迪BD eNOS抗体(BD Pharmingen, 610299)被用于被用于免疫印迹在小鼠样品上. Circ Res (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 1b
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样品上 (图 1b). J Clin Invest (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 7e
碧迪BD eNOS抗体(BD Biosciences, 61098)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 7e). Am J Physiol Lung Cell Mol Physiol (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 3c
碧迪BD eNOS抗体(BD Transduction Laboratories, 610296)被用于被用于免疫印迹在人类样品上 (图 3c). J Cereb Blood Flow Metab (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 图 2
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在小鼠样品上 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500; 图 1B
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 1B). Am J Physiol Regul Integr Comp Physiol (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 3d
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在人类样品上 (图 3d). Sci Rep (2016) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 人类; 图 3b
碧迪BD eNOS抗体(BD Biosciences, 612392)被用于被用于免疫印迹在人类样品上 (图 3b). Ann Thorac Surg (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 2b
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样品上 (图 2b). Ann Thorac Surg (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 5
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:200 (图 5). Theranostics (2016) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 大鼠; 1:1000; 图 3c
碧迪BD eNOS抗体(BD Transduction, 612393)被用于被用于免疫印迹在大鼠样品上浓度为1:1000 (图 3c). Rheumatology (Oxford) (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:2500; 图 3d
碧迪BD eNOS抗体(BD Transduction, 610297)被用于被用于免疫印迹在大鼠样品上浓度为1:2500 (图 3d). Rheumatology (Oxford) (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 1:1000; 图 5b
  • 免疫印迹; 小鼠; 1:1000; 图 6f
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 5b) 和 被用于免疫印迹在小鼠样品上浓度为1:1000 (图 6f). Oncotarget (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:2000; 图 4
碧迪BD eNOS抗体(Becton Dickinson, 610297)被用于被用于免疫印迹在大鼠样品上浓度为1:2000 (图 4). Front Neurosci (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫细胞化学; 人类; 图 3
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫细胞化学在人类样品上 (图 3). Tissue Eng Part C Methods (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 1a
碧迪BD eNOS抗体(BD Biosciences, 610299)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 1a). Angiogenesis (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 大鼠; 1:50; 图 S6
  • 免疫组化; 大鼠; 1:50; 图 2
碧迪BD eNOS抗体(BD transduction laboratories, 610296)被用于被用于免疫组化-石蜡切片在大鼠样品上浓度为1:50 (图 S6) 和 被用于免疫组化在大鼠样品上浓度为1:50 (图 2). Cardiovasc Res (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 3a
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在人类样品上 (图 3a). J Biol Chem (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在大鼠样品上浓度为1:500. Am J Physiol Heart Circ Physiol (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 1:1000
碧迪BD eNOS抗体(BD BioSciences, 610297)被用于被用于免疫印迹在人类样品上浓度为1:1000. Biol Reprod (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 4
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫印迹在人类样品上 (图 4). Micron (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:5000; 图 5a
碧迪BD eNOS抗体(BD Transduction Laboratories, 610296)被用于被用于免疫印迹在小鼠样品上浓度为1:5000 (图 5a). Biol Open (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 1
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100 (图 1). Am J Physiol Endocrinol Metab (2015) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 小鼠; 1:1000; 图 2
碧迪BD eNOS抗体(BD Transduction Laboratories, 612392)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 2). Am J Physiol Heart Circ Physiol (2015) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 人类; 1:1000; 图 1g
碧迪BD eNOS抗体(BD Transduction Laboratories, 612393)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 1g). Int J Obes (Lond) (2015) ncbi
小鼠 单克隆(31/eNOS)
  • 免疫印迹; 人类; 1:1000; 图 1g
碧迪BD eNOS抗体(BD Transduction Laboratories, 612707)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 1g). Int J Obes (Lond) (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 兔; 1:150
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫组化-石蜡切片在兔样品上浓度为1:150. Clin Exp Pharmacol Physiol (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:10,000; 图 5
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在小鼠样品上浓度为1:10,000 (图 5). J Appl Physiol (1985) (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 7
碧迪BD eNOS抗体(BD Transduction Laboratories, 610298)被用于被用于免疫印迹在小鼠样品上 (图 7). Cell Death Dis (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD, 610296)被用于被用于免疫细胞化学在人类样品上 和 被用于免疫印迹在人类样品上. Arch Biochem Biophys (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500; 图 3
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在大鼠样品上浓度为1:500 (图 3). Am J Physiol Heart Circ Physiol (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化; 大鼠; 1:500
碧迪BD eNOS抗体(BD transduction, 610297)被用于被用于免疫组化在大鼠样品上浓度为1:500. Exp Eye Res (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 兔; 1:100
碧迪BD eNOS抗体(BD Bioscience, 610297)被用于被用于免疫组化-石蜡切片在兔样品上浓度为1:100. Int J Exp Pathol (2014) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 小鼠; 1:500
碧迪BD eNOS抗体(BD Transduction Laboratories, 612392)被用于被用于免疫印迹在小鼠样品上浓度为1:500. PLoS ONE (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:300
碧迪BD eNOS抗体(Transduction Laboratories, 610296)被用于被用于免疫印迹在小鼠样品上浓度为1:300. J Sex Med (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样品上. Cardiovasc Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
碧迪BD eNOS抗体(BD Biosciences, 610299)被用于被用于免疫印迹在小鼠样品上浓度为1:1000. Mediators Inflamm (2013) ncbi
兔 多克隆
  • 免疫组化; 羊; 图 6
  • 免疫组化; 人类; 图 6
碧迪BD eNOS抗体(Transduction Laboratories, 610298)被用于被用于免疫组化在羊样品上 (图 6) 和 被用于免疫组化在人类样品上 (图 6). J Tissue Eng Regen Med (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 图 6
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫印迹在小鼠样品上 (图 6). J Am Heart Assoc (2013) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样品上. J Biol Chem (2013) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Biosciences, 612392)被用于被用于免疫印迹在人类样品上. J Biol Chem (2013) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 小鼠; 1:100
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:100. PLoS ONE (2012) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Transduction, 610296)被用于被用于免疫印迹在人类样品上. J Appl Physiol (1985) (2012) ncbi
默克密理博中国
兔 多克隆
  • 免疫细胞化学; 人类; 1:500; 图 4
默克密理博中国 eNOS抗体(Millipore, # 07-428)被用于被用于免疫细胞化学在人类样品上浓度为1:500 (图 4). Toxicol In Vitro (2014) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:500; 图 4
默克密理博中国 eNOS抗体(Millipore, # 07- 357)被用于被用于免疫细胞化学在人类样品上浓度为1:500 (图 4). Toxicol In Vitro (2014) ncbi
兔 多克隆
  • 免疫印迹; 小鼠
默克密理博中国 eNOS抗体(Millipore, 07-428)被用于被用于免疫印迹在小鼠样品上. J Physiol (2013) ncbi
西格玛奥德里奇
兔 多克隆
  • 免疫印迹; 大鼠; 1:500
西格玛奥德里奇 eNOS抗体(Sigma, N3893)被用于被用于免疫印迹在大鼠样品上浓度为1:500. Vascul Pharmacol (2015) ncbi
文章列表
  1. Yin D, Li Y, Fu C, Feng Y. Pro-Angiogenic Role of LncRNA HULC in Microvascular Endothelial Cells via Sequestrating miR-124. Cell Physiol Biochem. 2018;50:2188-2202 pubmed 出版商
  2. Zhan R, Wang F, Wu Y, Wang Y, Qian W, Liu M, et al. Nitric oxide induces epidermal stem cell de-adhesion by targeting integrin β1 and Talin via the cGMP signalling pathway. Nitric Oxide. 2018;78:1-10 pubmed 出版商
  3. Das A, Huang G, Bonkowski M, Longchamp A, Li C, Schultz M, et al. Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging. Cell. 2018;173:74-89.e20 pubmed 出版商
  4. Hwangbo C, Wu J, Papangeli I, Adachi T, Sharma B, Park S, et al. Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects. Sci Transl Med. 2017;9: pubmed 出版商
  5. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed 出版商
  6. Azimzadeh O, Subramanian V, Ständer S, Merl Pham J, Lowe D, Barjaktarovic Z, et al. Proteome analysis of irradiated endothelial cells reveals persistent alteration in protein degradation and the RhoGDI and NO signalling pathways. Int J Radiat Biol. 2017;93:920-928 pubmed 出版商
  7. Gupta A, Anjomani Virmouni S, Koundouros N, Dimitriadi M, Choo Wing R, Valle A, et al. PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation. Mol Cell. 2017;65:999-1013.e7 pubmed 出版商
  8. Yang G, Zhao Z, Qin T, Wang D, Chen L, Xiang R, et al. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation. FASEB J. 2017;31:2001-2012 pubmed 出版商
  9. Himori K, Abe M, Tatebayashi D, Lee J, Westerblad H, Lanner J, et al. Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension. PLoS ONE. 2017;12:e0169146 pubmed 出版商
  10. Merdzo I, Rutkai I, Sure V, McNulty C, Katakam P, Busija D. Impaired Mitochondrial Respiration in Large Cerebral Arteries of Rats with Type 2 Diabetes. J Vasc Res. 2017;54:1-12 pubmed 出版商
  11. Wang Q, Wu S, Zhu H, Ding Y, Dai X, Ouyang C, et al. Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L. Autophagy. 2017;13:404-422 pubmed 出版商
  12. Tancharoen W, Aungsuchawan S, Pothacharoen P, Markmee R, Narakornsak S, Kieodee J, et al. Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells. Acta Histochem. 2017;119:113-121 pubmed 出版商
  13. Lee S, Rho S, Park H, Park J, Kim J, Lee I, et al. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis. J Clin Invest. 2017;127:457-471 pubmed 出版商
  14. Ganta V, Choi M, Kutateladze A, Annex B. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease. Circ Res. 2017;120:282-295 pubmed 出版商
  15. Stratmann B, Engelbrecht B, Espelage B, Klusmeier N, Tiemann J, Gawlowski T, et al. Glyoxalase 1-knockdown in human aortic endothelial cells - effect on the proteome and endothelial function estimates. Sci Rep. 2016;6:37737 pubmed 出版商
  16. Wang S, Chennupati R, Kaur H, Iring A, Wettschureck N, Offermanns S. Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. J Clin Invest. 2016;126:4527-4536 pubmed 出版商
  17. Mahmoud A, Szczurek M, Blackburn B, Mey J, Chen Z, Robinson A, et al. Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles. Physiol Rep. 2016;4: pubmed
  18. Song C, Liu B, Shi Y, Liu N, Yan Y, Zhang J, et al. MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway. Oncotarget. 2016;7:71922-71936 pubmed 出版商
  19. Wong M, Kantores C, Ivanovska J, Jain A, Jankov R. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling. Am J Physiol Lung Cell Mol Physiol. 2016;311:L985-L999 pubmed 出版商
  20. Egholm C, Khammy M, Dalsgaard T, Mazur A, Tritsaris K, Hansen A, et al. GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol. 2016;311:H1214-H1224 pubmed 出版商
  21. Gross S, Devraj K, Feng Y, Macas J, Liebner S, Wieland T. Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation. J Cereb Blood Flow Metab. 2017;37:2471-2484 pubmed 出版商
  22. Vikram A, Kim Y, Kumar S, Li Q, Kassan M, JACOBS J, et al. Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1. Nat Commun. 2016;7:12565 pubmed 出版商
  23. Lee M, Tsai K, Hsu J, Shin S, Wu J, Yeh J. Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways. Sci Rep. 2016;6:31788 pubmed 出版商
  24. Spradley F, Sasser J, Musall J, Sullivan J, Granger J. Nitric oxide synthase-mediated blood pressure regulation in obese melanocortin-4 receptor-deficient pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2016;311:R851-R857 pubmed 出版商
  25. Hammers D, Sleeper M, Forbes S, Shima A, Walter G, Sweeney H. Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts. J Am Heart Assoc. 2016;5: pubmed 出版商
  26. Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86-90 pubmed
  27. Yu Q, Song W, Wang D, Zeng Y. Identification of blood vascular endothelial stem cells by the expression of protein C receptor. Cell Res. 2016;26:1079-1098 pubmed 出版商
  28. Tsai S, Huang P, Hsu Y, Peng Y, Lee C, Wang J, et al. Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci Rep. 2016;6:28612 pubmed 出版商
  29. Legeay S, Clere N, Hilairet G, Do Q, Bernard P, Quignard J, et al. The insect repellent N,N-diethyl-m-toluamide (DEET) induces angiogenesis via allosteric modulation of the M3 muscarinic receptor in endothelial cells. Sci Rep. 2016;6:28546 pubmed 出版商
  30. Burger D, Turner M, Munkonda M, Touyz R. Endothelial Microparticle-Derived Reactive Oxygen Species: Role in Endothelial Signaling and Vascular Function. Oxid Med Cell Longev. 2016;2016:5047954 pubmed 出版商
  31. Kotlarczyk M, Billaud M, Green B, Hill J, Shiva S, Kelley E, et al. Regional Disruptions in Endothelial Nitric Oxide Pathway Associated With Bicuspid Aortic Valve. Ann Thorac Surg. 2016;102:1274-81 pubmed 出版商
  32. Huang R, Harmsen S, Samii J, Karabeber H, Pitter K, Holland E, et al. High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe. Theranostics. 2016;6:1075-84 pubmed 出版商
  33. Burke S, Zsengellér Z, Khankin E, Lo A, Rajakumar A, Dupont J, et al. Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. J Clin Invest. 2016;126:2561-74 pubmed 出版商
  34. Eirin A, Ebrahimi B, Kwon S, Fiala J, Williams B, Woollard J, et al. Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension. J Am Heart Assoc. 2016;5: pubmed 出版商
  35. Totoson P, Maguin Gaté K, Prigent Tessier A, Monnier A, Verhoeven F, Marie C, et al. Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritis. Rheumatology (Oxford). 2016;55:1308-17 pubmed 出版商
  36. Tran Q, Firkins R, Giles J, Francis S, Matnishian V, Tran P, et al. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1. J Biol Chem. 2016;291:10805-23 pubmed 出版商
  37. Takır S, Gürel Gürevin E, Toprak A, Demirci Tansel C, UydeÅŸ DoÄŸan B. The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected. Exp Eye Res. 2016;145:401-411 pubmed 出版商
  38. Sönmez M, Dündar M. Ameliorative effects of pentoxifylline on NOS induced by diabetes in rat kidney. Ren Fail. 2016;38:605-13 pubmed 出版商
  39. Alonso F, Domingos Pereira S, Le Gal L, Derré L, Meda P, Jichlinski P, et al. Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion. Oncotarget. 2016;7:14015-28 pubmed 出版商
  40. Kim J, He X, Orr B, Wutz G, Hill V, Peters J, et al. Intact Cohesion, Anaphase, and Chromosome Segregation in Human Cells Harboring Tumor-Derived Mutations in STAG2. PLoS Genet. 2016;12:e1005865 pubmed 出版商
  41. Wu C, Chou H, Huang L, Lin Y, Chen C. Bubble CPAP Support after Discontinuation of Mechanical Ventilation Protects Rat Lungs with Ventilator-Induced Lung Injury. Respiration. 2016;91:171-9 pubmed 出版商
  42. Lee S, Kang B, Shin M, Min J, Heo C, Lee Y, et al. Chronic Stress Decreases Cerebrovascular Responses During Rat Hindlimb Electrical Stimulation. Front Neurosci. 2015;9:462 pubmed 出版商
  43. Baptista P, Moran E, Vyas D, Ribeiro M, Atala A, Sparks J, et al. Fluid Flow Regulation of Revascularization and Cellular Organization in a Bioengineered Liver Platform. Tissue Eng Part C Methods. 2016;22:199-207 pubmed 出版商
  44. Ge W, Yuan M, Ceylan A, Wang X, Ren J. Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism. Biochim Biophys Acta. 2016;1862:622-634 pubmed 出版商
  45. Messaoudi S, He Y, Gutsol A, Wight A, Hébert R, Vilmundarson R, et al. Endothelial Gata5 transcription factor regulates blood pressure. Nat Commun. 2015;6:8835 pubmed 出版商
  46. Leclercq A, Veillat V, Loriot S, Spuul P, Madonna F, Roques X, et al. A Methodology for Concomitant Isolation of Intimal and Adventitial Endothelial Cells from the Human Thoracic Aorta. PLoS ONE. 2015;10:e0143144 pubmed 出版商
  47. Sönmez M, Kılıç E, Karabulut D, Çilenk K, Deligönül E, Dündar M. Nitric oxide synthase in diabetic rat testicular tissue and the effects of pentoxifylline therapy. Syst Biol Reprod Med. 2016;62:22-30 pubmed 出版商
  48. Erkens R, Kramer C, Lückstädt W, Panknin C, Krause L, Weidenbach M, et al. Left ventricular diastolic dysfunction in Nrf2 knock out mice is associated with cardiac hypertrophy, decreased expression of SERCA2a, and preserved endothelial function. Free Radic Biol Med. 2015;89:906-17 pubmed 出版商
  49. Maleszewska M, Vanchin B, Harmsen M, Krenning G. The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence. Angiogenesis. 2016;19:9-24 pubmed 出版商
  50. Pellet Many C, Mehta V, Fields L, Mahmoud M, Lowe V, Evans I, et al. Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury. Cardiovasc Res. 2015;108:288-98 pubmed 出版商
  51. Sasaki N, Itakura Y, Toyoda M. Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells. J Biol Chem. 2015;290:25475-86 pubmed 出版商
  52. Chiang C, Uzoma I, Lane D, MemiÅ¡ević V, Alem F, Yao K, et al. A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection. Front Microbiol. 2015;6:683 pubmed 出版商
  53. Rutkai I, Dutta S, Katakam P, Busija D. Dynamics of enhanced mitochondrial respiration in female compared with male rat cerebral arteries. Am J Physiol Heart Circ Physiol. 2015;309:H1490-500 pubmed 出版商
  54. Nishimatsu H, Suzuki E, Saito Y, Niimi A, Nomiya A, Yamada D, et al. Neuromedin B Restores Erectile Function by Protecting the Cavernous Body and the Nitrergic Nerves from Injury in a Diabetic Rat Model. PLoS ONE. 2015;10:e0133874 pubmed 出版商
  55. Anaya H, Yi F, Boeldt D, Krupp J, Grummer M, Shah D, et al. Changes in Ca2+ Signaling and Nitric Oxide Output by Human Umbilical Vein Endothelium in Diabetic and Gestational Diabetic Pregnancies. Biol Reprod. 2015;93:60 pubmed 出版商
  56. Simplicio J, Resstel L, Tirapelli D, D Orléans Juste P, Tirapelli C. Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment. Vascul Pharmacol. 2015;73:124-37 pubmed 出版商
  57. Johlfs M, Gorjala P, Urasaki Y, Le T, Fiscus R. Capillary Isoelectric Focusing Immunoassay for Fat Cell Differentiation Proteomics. PLoS ONE. 2015;10:e0132105 pubmed 出版商
  58. Yokomori H, Ando W, Yoshimura K, Yamazaki H, Takahashi Y, Oda M. Increases in endothelial caveolin-1 and cavins correlate with cirrhosis progression. Micron. 2015;76:52-61 pubmed 出版商
  59. Jamiolkowski R, Kang S, Rodriguez A, Haseltine J, Galinat L, Jantzen A, et al. Increased yield of endothelial cells from peripheral blood for cell therapies and tissue engineering. Regen Med. 2015;10:447-60 pubmed 出版商
  60. Nasrallah R, Knezevic K, Thai T, Thomas S, Göttgens B, Lacaud G, et al. Endoglin potentiates nitric oxide synthesis to enhance definitive hematopoiesis. Biol Open. 2015;4:819-29 pubmed 出版商
  61. Kita T, Clermont A, Murugesan N, Zhou Q, Fujisawa K, Ishibashi T, et al. Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema. Diabetes. 2015;64:3588-99 pubmed 出版商
  62. Yamaleyeva L, Pulgar V, Lindsey S, Yamane L, Varagic J, McGee C, et al. Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity. Am J Physiol Endocrinol Metab. 2015;309:E84-94 pubmed 出版商
  63. Ng H, Jelinic M, Parry L, Leo C. Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice. Am J Physiol Heart Circ Physiol. 2015;309:H285-96 pubmed 出版商
  64. Nishimatsu H, Suzuki E, Saito Y, Niimi A, Nomiya A, Fukuhara H, et al. Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice. PLoS ONE. 2015;10:e0124129 pubmed 出版商
  65. Pardo F, Silva L, Sáez T, Salsoso R, Gutiérrez J, Sanhueza C, et al. Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond). 2015;39:1264-73 pubmed 出版商
  66. Smith R, Klein R, Kruzliak P, Zulli A. Role of Peptide YY in blood vessel function and atherosclerosis in a rabbit model. Clin Exp Pharmacol Physiol. 2015;42:648-52 pubmed 出版商
  67. Liu Z, Jiang C, Zhang J, Liu B, Du Q. Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities. J Diabetes. 2016;8:324-35 pubmed 出版商
  68. Kishikawa T, Otsuka M, Tan P, Ohno M, Sun X, Yoshikawa T, et al. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Oncotarget. 2015;6:8339-52 pubmed
  69. Holloway T, Bloemberg D, da Silva M, Simpson J, Quadrilatero J, Spriet L. High intensity interval and endurance training have opposing effects on markers of heart failure and cardiac remodeling in hypertensive rats. PLoS ONE. 2015;10:e0121138 pubmed 出版商
  70. Hong Y, Frugier T, Zhang X, Murphy R, Lynch G, Betik A, et al. Glucose uptake during contraction in isolated skeletal muscles from neuronal nitric oxide synthase μ knockout mice. J Appl Physiol (1985). 2015;118:1113-21 pubmed 出版商
  71. Pajaud J, Ribault C, Ben Mosbah I, Rauch C, Henderson C, Bellaud P, et al. Glutathione transferases P1/P2 regulate the timing of signaling pathway activations and cell cycle progression during mouse liver regeneration. Cell Death Dis. 2015;6:e1598 pubmed 出版商
  72. Azimzadeh O, Sievert W, Sarioglu H, Merl Pham J, Yentrapalli R, Bakshi M, et al. Integrative proteomics and targeted transcriptomics analyses in cardiac endothelial cells unravel mechanisms of long-term radiation-induced vascular dysfunction. J Proteome Res. 2015;14:1203-19 pubmed 出版商
  73. Golob M, Tian L, Wang Z, Zimmerman T, Caneba C, Hacker T, et al. Mitochondria DNA mutations cause sex-dependent development of hypertension and alterations in cardiovascular function. J Biomech. 2015;48:405-12 pubmed 出版商
  74. Wang S, Amato K, Song W, Youngblood V, Lee K, Boothby M, et al. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways. Mol Cell Biol. 2015;35:1299-313 pubmed 出版商
  75. Chang K, Nayak R, Roy S, Perumbeti A, Wellendorf A, Bezold K, et al. Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial ATâ‚‚R and cytoskeletal dysregulation. Nat Commun. 2015;6:5914 pubmed 出版商
  76. Hu J, Ma S, Zou S, Li X, Cui P, WeijdegÃ¥rd B, et al. The regulation of nitric oxide synthase isoform expression in mouse and human fallopian tubes: potential insights for ectopic pregnancy. Int J Mol Sci. 2014;16:49-67 pubmed 出版商
  77. Lee S, Lee K, Lee J, Kang S, Kim H, Asahara T, et al. Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling. Stem Cells. 2015;33:1490-500 pubmed 出版商
  78. Yu C, Luo X, Duquette N, Thorin Trescases N, Thorin E. Knockdown of angiopoietin like-2 protects against angiotensin II-induced cerebral endothelial dysfunction in mice. Am J Physiol Heart Circ Physiol. 2015;308:H386-97 pubmed 出版商
  79. Tang Y, Yin Y, Miao L, Wei B, Zhai K, Ji G. Nitric oxide enhances extracellular ATP induced Ca²⁺ oscillation in HeLa cells. Arch Biochem Biophys. 2015;565:68-75 pubmed 出版商
  80. Pitts N, Mykles D. Nitric oxide production and sequestration in the sinus gland of the green shore crab Carcinus maenas. J Exp Biol. 2015;218:353-62 pubmed 出版商
  81. Ansari M, Roberts K, Scheff S. A time course of NADPH-oxidase up-regulation and endothelial nitric oxide synthase activation in the hippocampus following neurotrauma. Free Radic Biol Med. 2014;77:21-9 pubmed 出版商
  82. Rutkai I, Katakam P, Dutta S, Busija D. Sustained mitochondrial functioning in cerebral arteries after transient ischemic stress in the rat: a potential target for therapies. Am J Physiol Heart Circ Physiol. 2014;307:H958-66 pubmed 出版商
  83. Shibeeb O, Wood J, Casson R, Chidlow G. Effects of a conventional photocoagulator and a 3-ns pulse laser on preconditioning responses and retinal ganglion cell survival after optic nerve crush. Exp Eye Res. 2014;127:77-90 pubmed 出版商
  84. Habiyakare B, Alsaadon H, Mathai M, Hayes A, Zulli A. Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7). Int J Exp Pathol. 2014;95:290-5 pubmed 出版商
  85. Yu J, Wang Q, Wang H, Lu W, Li W, Qin Z, et al. Activation of liver X receptor enhances the proliferation and migration of endothelial progenitor cells and promotes vascular repair through PI3K/Akt/eNOS signaling pathway activation. Vascul Pharmacol. 2014;62:150-61 pubmed 出版商
  86. Tobin G, Zhang J, Goodwin D, Stewart S, Xu L, Knapton A, et al. The role of eNOS phosphorylation in causing drug-induced vascular injury. Toxicol Pathol. 2014;42:709-24 pubmed 出版商
  87. Bölck B, Ibrahim M, Steinritz D, Morguet C, Dühr S, Suhr F, et al. Detection of key enzymes, free radical reaction products and activated signaling molecules as biomarkers of cell damage induced by benzo[a]pyrene in human keratinocytes. Toxicol In Vitro. 2014;28:875-84 pubmed 出版商
  88. Swärd K, Albinsson S, Rippe C. Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice. PLoS ONE. 2014;9:e92428 pubmed 出版商
  89. Tavukçu H, Sener T, Tinay I, Akbal C, Ersahin M, Cevik O, et al. Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats. Clin Exp Pharmacol Physiol. 2014;41:309-16 pubmed 出版商
  90. Onan B, Erkanli K, Onan I, Ersoy B, Çanıllıoğlu Y, Senturk G, et al. The impact of vessel clamps on endothelial integrity and function of saphenous vein grafts. Ann Vasc Surg. 2014;28:1113-22 pubmed 出版商
  91. Shao D, Zhai P, Del Re D, Sciarretta S, Yabuta N, Nojima H, et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315 pubmed 出版商
  92. Song K, Chung J, Choi M, Jin H, Yin G, Kwon M, et al. Effectiveness of intracavernous delivery of adenovirus encoding Smad7 gene on erectile function in a mouse model of cavernous nerve injury. J Sex Med. 2014;11:51-63 pubmed 出版商
  93. Fessner A, Esser J, Bluhm F, Grundmann S, Zhou Q, Patterson C, et al. The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner. Cardiovasc Res. 2014;101:247-55 pubmed 出版商
  94. Raposo C, Nunes A, Luna R, Araújo S, da Cruz Höfling M, Peixoto C. Sildenafil (Viagra) protective effects on neuroinflammation: the role of iNOS/NO system in an inflammatory demyelination model. Mediators Inflamm. 2013;2013:321460 pubmed 出版商
  95. Weber B, Kehl D, Bleul U, Behr L, Sammut S, Frese L, et al. In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells. J Tissue Eng Regen Med. 2016;10:52-70 pubmed 出版商
  96. Xiong Y, Yu Y, Montani J, Yang Z, Ming X. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J Am Heart Assoc. 2013;2:e000096 pubmed 出版商
  97. Hou Z, Nie C, Si Z, Ma Y. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1?. Diabetes Res Clin Pract. 2013;101:62-71 pubmed 出版商
  98. Weyers J, Schwartz S, Minami E, Carlson D, Dupras S, Weitz K, et al. Effects of cell grafting on coronary remodeling after myocardial infarction. J Am Heart Assoc. 2013;2:e000202 pubmed 出版商
  99. Zhu X, Li P, Yang Y, Liu M. Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats. PLoS ONE. 2013;8:e62731 pubmed 出版商
  100. Haeussler D, Pimentel D, Hou X, Burgoyne J, Cohen R, Bachschmid M. Endomembrane H-Ras controls vascular endothelial growth factor-induced nitric-oxide synthase-mediated endothelial cell migration. J Biol Chem. 2013;288:15380-9 pubmed 出版商
  101. Leiria L, Sollon C, Báu F, Mónica F, D Ancona C, De Nucci G, et al. Insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response-dependent insulin resistance as a cause of obesity-associated overactive bladder. J Physiol. 2013;591:2259-73 pubmed 出版商
  102. Helmy K, Halliday J, Fomchenko E, Setty M, Pitter K, Hafemeister C, et al. Identification of global alteration of translational regulation in glioma in vivo. PLoS ONE. 2012;7:e46965 pubmed 出版商
  103. Ives S, Andtbacka R, Kwon S, Shiu Y, Ruan T, Noyes R, et al. Heat and ?1-adrenergic responsiveness in human skeletal muscle feed arteries: the role of nitric oxide. J Appl Physiol (1985). 2012;113:1690-8 pubmed 出版商
  104. Pan C, Wang J, Liu W, Liu L, Jing L, Yang Y, et al. Low tidal volume protects pulmonary vasomotor function from "second-hit" injury in acute lung injury rats. Respir Res. 2012;13:77 pubmed 出版商